13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Stand E8

2017 Edition

InfiCure Bio

Sweden

InfiCure Bio has developed a new and unique pre-clinical mouse model, the N-IF mouse, which spontaneously develops fibrosis in multiple organs.
We offer expert led, tailored, high-quality drug validation services for R&D companies and CRO’s.
Our unique model offers extraordinary research advantages; is 100 percent reproducible, has a pathological progress similar to humans and displays a fibrosis preceded by inflammation.
Inficure Bio will break the status quo in anti-fibrotic drug development

Scroll to Top
  • No products in the cart.